B2M and diffuse large B-cell lymphoma: β2M mutations are observed in 29% of DLBCL cases (Challa-Malladi et al., 2011), and cytoplasmic β2M isoforms were detected in 48.4% MHC-I-negative DLBCL cases (Nijland et al., 2017).